Compare Mirae Asset Healthcare Fund vs UTI Healthcare Fund
Risk
Very High
Very High
Rating
3.0
4.0
Min SIP Amount
₹99
₹500
Expense Ratio
2.31
2.82
NAV
₹47.35
₹349.81
Fund Started
11 Jun 2018
01 Aug 2005
Fund Size
₹2939.23 Cr
₹1143.58 Cr
Exit Load
Exit load of 1% if redeemed within 1 year.
Exit load of 1% if redeemed within 30 days.
1 Year
12.52%
9.98%
3 Year
24.57%
25.97%
5 Year
14.27%
13.92%
Equity
99.96%
95.25%
Cash
0.04%
4.74%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 11.76% |
Divi's Laboratories Ltd. | 8.23% |
Glenmark Pharmaceuticals Ltd. | 7.12% |
JB Chemicals & Pharmaceuticals Ltd. | 6.39% |
Apollo Hospitals Enterprise Ltd. | 5.93% |
Lupin Ltd. | 4.57% |
Dr. Reddy's Laboratories Ltd. | 4.44% |
Aurobindo Pharma Ltd. | 4.22% |
Fortis Healthcare Ltd. | 4.06% |
Laurus Labs Ltd. | 3.70% |
Sun Pharmaceutical Industries Ltd. | 9.49% |
Ajanta Pharma Ltd. | 5.84% |
Lupin Ltd. | 4.23% |
Apollo Hospitals Enterprise Ltd. | 3.54% |
Divi's Laboratories Ltd. | 3.45% |
Glenmark Pharmaceuticals Ltd. | 3.35% |
Dr. Reddy's Laboratories Ltd. | 3.35% |
Gland Pharma Ltd. | 3.30% |
Fortis Healthcare Ltd. | 3.23% |
Alkem Laboratories Ltd. | 3.21% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
11 Jun 2018
01 Aug 2005
